Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland:

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

• Eleftheria Vasileiou, PhD *
• Prof Colin R Simpson, PhD *
• Ting Shi, PhD *
• Steven Kerr, PhD *
• Utkarsh Agrawal, PhD
• Ashley Akbari, MSc
• et al.
• Show all authors
• Show footnotes
• 
  
• 
  
• https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00677-2/fulltext
  

Household COVID-19 risk and in-person schooling | Science

https://science.sciencemag.org/content/early/2021/04/28/science.abh2939.full


Enviado desde mi iPhone

en algunos colectivos una solo dosis no genera inmunidad suficiente.

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00213-8/fulltext#%20

The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom | medRxiv

https://www.medrxiv.org/content/10.1101/2021.04.22.21255911v1

El ECDC abre la puerta a que los vacunados no usen la mascarilla cuando se reúnan con personas sin riesgo - JANO.es - ELSEVIER

https://www.jano.es/noticia-el-ecdc-abre-puerta-que-31077

Tratamiento inmunosupresor y vacunas covid.

Pacientes con tratamiento inmunosupresor y vacunación frente a la COVID-19.La pregunta original del usuario era "Respecto a los pacientes con tratamiento inmunosupresor y la vacuna contra la COVID-19, ¿cuál es la recomendación actual?, ¿qué vacuna es la más recomendable en estos casos?"Patients with immunosuppressive treatment and vaccination against COVID-19.http://www.murciasalud.es/preevid/24146

Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination

https://www.biorxiv.org/content/10.1101/2021.04.21.440862v1